NCT00120536View on ClinicalTrials.gov

Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY